Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP).
Fattovich G, Giustina G, Degos F, Diodati G, Tremolada F, Nevens F, Almasio P, Solinas A, Brouwer JT, Thomas H, Realdi G, Corrocher R, Schalm SW. Fattovich G, et al. Among authors: degos f. J Hepatol. 1997 Jul;27(1):201-5. doi: 10.1016/s0168-8278(97)80302-9. J Hepatol. 1997. PMID: 9252096 Clinical Trial.
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.
Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, Solinas A, Mura D, Brouwer JT, Thomas H, Njapoum C, Casarin C, Bonetti P, Fuschi P, Basho J, Tocco A, Bhalla A, Galassini R, Noventa F, Schalm SW, Realdi G. Fattovich G, et al. Among authors: degos f. Gastroenterology. 1997 Feb;112(2):463-72. doi: 10.1053/gast.1997.v112.pm9024300. Gastroenterology. 1997. PMID: 9024300
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP).
Fattovich G, Giustina G, Sanchez-Tapias J, Quero C, Mas A, Olivotto PG, Solinas A, Almasio P, Hadziyannis S, Degos F, de Moura MC, Krogsgaard K, Pantalena M, Realdi G, Corrocher R, Schalm SW. Fattovich G, et al. Among authors: degos f. Am J Gastroenterol. 1998 Jun;93(6):896-900. doi: 10.1111/j.1572-0241.1998.00272.x. Am J Gastroenterol. 1998. PMID: 9647014
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe.
Fattovich G, Ribero ML, Pantalena M, Diodati G, Almasio P, Nevens F, Tremolada F, Degos F, Rai J, Solinas A, Mura D, Tocco A, Zagni I, Fabris F, Lomonaco L, Noventa F, Realdi G, Schalm SW, Tagger A; Eurohep Study Group on Viral Hepatitis. Fattovich G, et al. Among authors: degos f. J Viral Hepat. 2001 May;8(3):206-16. doi: 10.1046/j.1365-2893.2001.00291.x. J Viral Hepat. 2001. PMID: 11380799
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 Group.
Degos F, Daurat V, Chevret S, Gayno S, Bastie A, Riachi G, Bartolomei-Portal I, Barange K, Moussalli J, Naveau S, Bailly F, Chaumet-Riffaud P, Chastang C. Degos F, et al. J Hepatol. 1998 Aug;29(2):224-32. doi: 10.1016/s0168-8278(98)80007-x. J Hepatol. 1998. PMID: 9722203 Clinical Trial.
Re-treatment with interferon alfa of patients with chronic hepatitis C.
Chow WC, Boyer N, Pouteau M, Castelnau C, Martinot-Peignoux M, Martins-Amado V, Degos F, Maghinici C, Sinegre M, Benhamou JP, Degott C, Erlinger S, Marcellin P. Chow WC, et al. Among authors: degos f. Hepatology. 1998 Apr;27(4):1144-8. doi: 10.1002/hep.510270432. Hepatology. 1998. PMID: 9537456
173 results